Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Internal and Emergency Medicine
|
July 4, 2024
Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study
Eva Soler-Espejo, José Miguel Rivera-Caravaca, José Daniel Bru-Cánovas, et al.
Cardiovascular Diabetology
|
July 10, 2025
Remnant-to-LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study
Eva Soler-Espejo, Yang Chen, José Miguel Rivera-Caravaca, et al.
Clinical Case Reports
|
April 2, 2025
Intestinal Perforation Secondary to Bortezomib-Induced Autonomic Neuropathy
Jose Antonio Sánchez Salas, Maria Jose Moreno Belmonte, Andrea Poveda García, et al.
Heart Rhythm
|
September 13, 2025
Phenotype-guided risk stratification in anticoagulated atrial fibrillation patients: Cluster analysis of the Murcia AF Project III (MAFP-III)
Eva Soler-Espejo, María Pilar Ramos-Bratos, Yang Chen, et al.
European Journal of Preventive Cardiology
|
January 29, 2026
Identification of Biomarkers for Predicting New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
Darío Mandaglio-Collados, María Pilar Ramos-Bratos, José Miguel Rivera-Caravaca, et al.
Cardiovascular Diabetology
|
October 1, 2025
Relation of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio to residual risk in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF Project III cohort
Eva Soler-Espejo, Yang Chen, José Miguel Rivera-Caravaca, et al.
Diabetes, Obesity & Metabolism
|
December 4, 2025
Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort
Eva Soler-Espejo, Yang Chen, José Miguel Rivera-Caravaca, et al.
The Journal of Nutrition, Health & Aging
|
November 30, 2024
Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation
Eva Soler-Espejo, Beatriz Ángela Zazo-Luengo, José Miguel Rivera-Caravaca, et al.
Journal of Global Health
|
April 16, 2026
Impact of seasonal temperature variations on adverse outcomes in atrial fibrillation: comparative insights from Vigo and Murcia cohorts
Eva Soler-Espejo, María Pilar Ramos-Bratos, Inmaculada González-Bermúdez, et al.
Medicina Clinica
|
June 4, 2025
Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries
José Miguel Rivera-Caravaca, Danilo Menichelli, Daniele Pastori, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Internal and Emergency Medicine
|
July 4, 2024
Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study
Eva Soler-Espejo, José Miguel Rivera-Caravaca, José Daniel Bru-Cánovas, et al.
Cardiovascular Diabetology
|
July 10, 2025
Remnant-to-LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study
Eva Soler-Espejo, Yang Chen, José Miguel Rivera-Caravaca, et al.
Clinical Case Reports
|
April 2, 2025
Intestinal Perforation Secondary to Bortezomib-Induced Autonomic Neuropathy
Jose Antonio Sánchez Salas, Maria Jose Moreno Belmonte, Andrea Poveda García, et al.
Heart Rhythm
|
September 13, 2025
Phenotype-guided risk stratification in anticoagulated atrial fibrillation patients: Cluster analysis of the Murcia AF Project III (MAFP-III)
Eva Soler-Espejo, María Pilar Ramos-Bratos, Yang Chen, et al.
European Journal of Preventive Cardiology
|
January 29, 2026
Identification of Biomarkers for Predicting New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
Darío Mandaglio-Collados, María Pilar Ramos-Bratos, José Miguel Rivera-Caravaca, et al.
Cardiovascular Diabetology
|
October 1, 2025
Relation of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio to residual risk in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF Project III cohort
Eva Soler-Espejo, Yang Chen, José Miguel Rivera-Caravaca, et al.
Diabetes, Obesity & Metabolism
|
December 4, 2025
Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort
Eva Soler-Espejo, Yang Chen, José Miguel Rivera-Caravaca, et al.
The Journal of Nutrition, Health & Aging
|
November 30, 2024
Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation
Eva Soler-Espejo, Beatriz Ángela Zazo-Luengo, José Miguel Rivera-Caravaca, et al.
Journal of Global Health
|
April 16, 2026
Impact of seasonal temperature variations on adverse outcomes in atrial fibrillation: comparative insights from Vigo and Murcia cohorts
Eva Soler-Espejo, María Pilar Ramos-Bratos, Inmaculada González-Bermúdez, et al.
Medicina Clinica
|
June 4, 2025
Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries
José Miguel Rivera-Caravaca, Danilo Menichelli, Daniele Pastori, et al.
Page
of 3